香港珍稀濒危植物的分布及保育

在第一批共３８８种中国重点保护的珍稀濒危植物中,有１４种分布于香港特别行政区。其中蕨类植物２种,裸子植物２种,被子植物１０种。此１４种珍稀濒危植物,除了狭叶瓶尔小草外,亦分布于广东省。而其中被列为国家级渐危种类的土沉香及白桂木,在香港则较为常见。本文阐述了此１４种珍稀濒危植物在香港的分布情况及其保育工作。     

用ITS序列确定小麦B基因组的可能供体间的关系

对小麦B基因组的可能供体山羊草属Aegilops sect．Sitopsis的5个种的核糖体DNA的内部转 录区(ITS)进行了PCR扩增和克隆,井测定ITSl和ITS2的序列,用ITSl+ITS2的序列重建了 Aegilops sect．Sitopsis中5个种的系统发育关系。结果表明,斯卑尔脱山羊草Ae．speltoides是sect． Sitopsis中特殊的一个种,它与该组其余4种间的平均遗传距离是后者彼此间平均遗传距离的3倍,Ae． speltoides与同组其余4个种的分离要比后者相互间的分离早得多;在拟斯卑尔脱组Sect．Sitopsis的5 个种中,长柱山羊草Ae．longissima与沙融山羊草Ae．sharonensis的关系最近。ITS序列可以进一步用来作为确定B基因组起源的分子标记。     

基于结构分类的蛋白质折叠模式识别方法

对用于折叠模式识别的蛋白质结构数据库进行结构分类,构建了四个分类库：Ａｌ－α库,Ａｌ－β库,α／β库,α＋β库和一个总库,然后分别统计出不同灵敏度的匹配评估函数（平均势）。对不同的平均势,不同结构类型的蛋白进行的检验发现：来源于α／β库的平均势预测能力最强,来源于Ａｌ－α库的平均势预测能力最弱;对α／β蛋白的预测成功率最高,对Ａｌ－α蛋白的预测成功率最低。这与α／β蛋白结构最规则,Ａｌ－α蛋白未加入辅基不能反映出结构的全部特征是相一致的     

On Exact Unconditional Test for Linear Trend in Dose‐Response Studies

The one‐degree‐of‐freedom Cochran‐Armitage (C‐A) test statistic for linear trend has been widely applied in various dose‐response studies (e.g., anti‐ulcer medications and short‐term antibiotics, animal carcinogenicity bioassays and occupational toxicant studies). This approximate statistic relies, however, on asymptotic theory that is reliable only when the sample sizes are reasonably large and well balanced across dose levels. For small, sparse, or skewed data, the asymptotic theory is suspect and exact conditional method (based on the C‐A statistic) seems to provide a dependable alternative. Unfortunately, the exact conditional method is only practical for the linear logistic model from which the sufficient statistics for the regression coefficients can be obtained explicitly. In this article, a simple and efficient recursive polynomial multiplication algorithm for exact unconditional test (based on the C‐A statistic) for detecting a linear trend in proportions is derived. The method is applicable for all choices of the model with monotone trend including logistic, probit, arcsine, extreme value and one hit. We also show that this algorithm can be easily extended to exact unconditional power calculation for studies with up to a moderately large sample size. A real example is given to illustrate the applicability of the proposed method.     

Identification of mitogen-activated protein kinase-activated protein kinase-2 as a vimentin kinase activated by okadaic acid in 9L rat brain tumor cells

Organization of intermediate filament, a major component of cytoskeleton, is regulated by protein phosphorylation/dephosphorylation, which is a dynamic process governed by a balance between the activities of involved protein kinases and phosphatases. Blocking dephosphorylation by protein phosphatase inhibitors such as okadaic acid (OA) leads to an apparent activation of protein kinase(s) and to genuine activation of phosphatase-regulated protein kinase(s). Treatment of 9L rat brain tumor cells with OA results in a drastically increased phosphorylation of vimentin, an intermediate filament protein. In-gel renaturing assays and in vitro kinase assays using vimentin as the exogenous substrate indicate that certain protein kinase(s) is activated in OA-treated cells. With specific protein kinase inhibitors, we show the possible involvement of the cdc2 kinase- and p38 mitogen-activated protein kinase (p38^MAPK)-mediated pathways in this process. Subsequent in vitro assays demonstrate that vimentin may serve as an excellent substrate for MAPK-activated protein kinase-2 (MAPKAPK-2), the downstream effector of p38^MAPK, and that MAPKAPK-2 is activated with OA treatment. Comparative analysis of tryptic phosphopeptide maps also indicates that corresponding phosphopeptides emerged in vimentin from OA-treated cells and were phosphorylated by MAPKAPK-2. Taken together, the results clearly demonstrate that MAPKAPK-2 may function as a vimentin kinase in vitro and in vivo. These findings shed new light on the possible involvement of the p38^MAPK signaling cascade, via MAPKAPK-2, in the maintenance of integrity and possible physiological regulation of intermediate filaments. J. Cell. Biochem. 71:169–181, 1998. © 1998 Wiley-Liss, Inc.     

Focus: Rare Disease: Prostatic Schwannoma Presenting with Prostate-specific Antigen Elevation: A Case Report

Introduction: Schwannoma of the male genital system is very uncommon and is mostly treated by surgery. However, prostatic schwannoma presenting with elevated prostate-specific antigen (PSA) level and treated conservatively are extremely rare. Case presentation: Herein, we present a rare case of a prostatic schwannoma in a 65-year-old man who initially presented with an elevated PSA level. Digital rectal examination revealed an enlarged prostate with a palpable hard nodule on the left side. Transrectal ultrasonography revealed an enlarged prostate with a well-defined homogeneously hypoechoic nodule in the left peripheral lobe. Biopsy was done, and histopathology revealed a prostatic schwannoma. Conservative treatment with regular image follow-up was done per the patient’s preference. Mild PSA progression but no worsening of symptoms was found in 6 years of follow-up. Conclusions: PSA elevation could be a rare presentation of prostatic schwannoma. Treatment options other than surgery, such as conservative treatment with close observation, could be feasible for these rare tumors and long-term survivorship can be achieved.